Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ESRRA_ESR2
Z-value: 3.48
Motif logo
Transcription factors associated with ESRRA_ESR2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ESRRA
|
ENSG00000173153.17 | estrogen related receptor alpha |
|
ESR2
|
ENSG00000140009.19 | estrogen receptor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESRRA | hg38_v1_chr11_+_64305550_64305584 | 0.58 | 5.2e-04 | Click! |
| ESR2 | hg38_v1_chr14_-_64338096_64338124 | -0.29 | 1.1e-01 | Click! |
Activity profile of ESRRA_ESR2 motif
Sorted Z-values of ESRRA_ESR2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ESRRA_ESR2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 18.6 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 4.2 | 16.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 4.2 | 4.2 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 4.1 | 24.8 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 3.8 | 15.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 3.6 | 14.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 3.6 | 10.9 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 3.6 | 10.8 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 3.5 | 10.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 3.3 | 10.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 3.2 | 12.9 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
| 3.2 | 9.5 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
| 3.1 | 6.2 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 2.9 | 11.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 2.6 | 7.7 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 2.2 | 15.4 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 2.1 | 26.8 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 2.1 | 6.2 | GO:1902688 | regulation of NAD metabolic process(GO:1902688) |
| 2.0 | 8.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 2.0 | 8.0 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 2.0 | 7.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 2.0 | 5.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.9 | 17.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 1.9 | 5.7 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.8 | 18.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.8 | 3.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 1.8 | 21.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 1.8 | 5.3 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.7 | 8.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.7 | 6.8 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 1.7 | 8.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.7 | 5.0 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 1.7 | 10.0 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.7 | 10.0 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.6 | 4.9 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 1.6 | 4.8 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 1.6 | 14.3 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.6 | 4.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 1.6 | 1.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 1.6 | 9.3 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 1.5 | 6.2 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.5 | 4.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 1.5 | 4.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.5 | 12.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.5 | 6.0 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 1.5 | 7.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 1.5 | 14.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 1.5 | 7.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.4 | 4.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.4 | 4.3 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.4 | 8.5 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 1.4 | 13.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.4 | 13.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.4 | 1.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 1.3 | 1.3 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 1.3 | 3.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.3 | 40.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 1.3 | 2.6 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 1.3 | 5.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 1.3 | 3.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 1.2 | 9.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.2 | 12.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 1.2 | 3.7 | GO:0030221 | basophil differentiation(GO:0030221) |
| 1.2 | 3.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.2 | 3.7 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 1.2 | 8.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.2 | 21.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.2 | 3.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 1.2 | 5.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.2 | 3.5 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.1 | 4.6 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 1.1 | 21.8 | GO:0008228 | opsonization(GO:0008228) |
| 1.1 | 6.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.1 | 9.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.1 | 5.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.1 | 5.6 | GO:0032796 | uropod organization(GO:0032796) |
| 1.1 | 5.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 1.1 | 3.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.1 | 1.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 1.1 | 4.4 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.1 | 2.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.1 | 6.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 1.1 | 5.4 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 1.1 | 3.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.1 | 4.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.0 | 3.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 1.0 | 6.2 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 1.0 | 3.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.0 | 4.1 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.0 | 4.0 | GO:2000733 | regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
| 1.0 | 6.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 1.0 | 9.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 1.0 | 2.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.0 | 2.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 1.0 | 2.9 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.0 | 4.9 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 1.0 | 4.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.0 | 5.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 1.0 | 4.8 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 1.0 | 4.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.0 | 2.9 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 1.0 | 1.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.9 | 2.8 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.9 | 2.8 | GO:0035744 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) T-helper 1 cell cytokine production(GO:0035744) |
| 0.9 | 3.8 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.9 | 3.8 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 0.9 | 4.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.9 | 2.8 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.9 | 0.9 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.9 | 12.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.9 | 0.9 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.9 | 0.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.9 | 10.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.9 | 2.7 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.9 | 10.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.9 | 4.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.9 | 2.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.9 | 2.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.9 | 6.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.9 | 28.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.9 | 3.5 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.9 | 2.6 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.9 | 1.7 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.9 | 2.6 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.9 | 3.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.8 | 3.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.8 | 2.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.8 | 0.8 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.8 | 8.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.8 | 2.5 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.8 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.8 | 2.5 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.8 | 14.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.8 | 2.5 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.8 | 1.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.8 | 18.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.8 | 2.5 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.8 | 4.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.8 | 4.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.8 | 6.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.8 | 2.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.8 | 14.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.8 | 2.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.8 | 4.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.8 | 4.7 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.8 | 2.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.8 | 3.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.8 | 5.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.8 | 2.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.8 | 2.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.8 | 6.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.8 | 3.8 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 0.8 | 3.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 0.8 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
| 0.7 | 3.7 | GO:0071726 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.7 | 2.2 | GO:1903570 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.7 | 3.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.7 | 3.0 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.7 | 1.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.7 | 1.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.7 | 2.2 | GO:2000452 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.7 | 58.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.7 | 2.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.7 | 4.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.7 | 2.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.7 | 4.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.7 | 3.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.7 | 14.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.7 | 1.4 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.7 | 5.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.7 | 1.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.7 | 4.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.7 | 4.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.7 | 2.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.7 | 5.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.7 | 3.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.7 | 10.2 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.7 | 2.0 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.7 | 3.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.7 | 3.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.7 | 8.1 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.7 | 4.0 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.7 | 2.0 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.7 | 2.7 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.7 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.7 | 41.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.7 | 2.7 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.7 | 2.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 | 2.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.7 | 5.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 0.6 | 1.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.6 | 1.9 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.6 | 2.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 | 1.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.6 | 3.9 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.6 | 2.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.6 | 26.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
| 0.6 | 1.9 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.6 | 3.8 | GO:0072615 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.6 | 1.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.6 | 0.6 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.6 | 5.6 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.6 | 1.9 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.6 | 1.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.6 | 11.1 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.6 | 2.5 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.6 | 2.5 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.6 | 1.2 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.6 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.6 | 1.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
| 0.6 | 3.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.6 | 3.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.6 | 1.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.6 | 1.8 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.6 | 7.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.6 | 1.2 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.6 | 8.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.6 | 4.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.6 | 4.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.6 | 0.6 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.6 | 8.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.6 | 1.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.6 | 2.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.6 | 2.3 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.6 | 1.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.6 | 3.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.6 | 5.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.6 | 4.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.6 | 1.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.6 | 0.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.6 | 1.7 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.6 | 2.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.6 | 4.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.6 | 1.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.6 | 2.8 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.6 | 6.7 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.6 | 1.7 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.6 | 6.7 | GO:0015747 | urate transport(GO:0015747) |
| 0.6 | 3.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.6 | 2.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.6 | 0.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.6 | 1.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.6 | 0.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.5 | 2.7 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 | 1.6 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.5 | 2.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 1.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.5 | 4.9 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.5 | 2.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.5 | 4.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.5 | 2.7 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.5 | 3.8 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.5 | 0.5 | GO:0003292 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.5 | 1.6 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.5 | 8.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.5 | 1.6 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.5 | 4.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.5 | 1.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 3.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 3.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.5 | 2.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.5 | 1.6 | GO:0002339 | B cell selection(GO:0002339) |
| 0.5 | 2.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.5 | 2.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 1.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.5 | 5.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.5 | 1.5 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 0.5 | 1.5 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.5 | 3.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.5 | 5.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.5 | 1.5 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.5 | 0.5 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) |
| 0.5 | 2.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.5 | 7.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 1.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 | 2.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.5 | 2.0 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.5 | 3.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 | 2.0 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) regulation of microglial cell activation(GO:1903978) |
| 0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 | 1.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.5 | 2.0 | GO:0060022 | hard palate development(GO:0060022) |
| 0.5 | 1.5 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
| 0.5 | 7.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.5 | 1.0 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.5 | 29.4 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.5 | 2.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.5 | 2.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.5 | 3.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.5 | 1.9 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 | 1.4 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 0.5 | 2.4 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 | 3.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.5 | 1.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 | 2.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.5 | 2.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.5 | 3.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.5 | 8.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.5 | 2.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 1.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 | 1.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.5 | 1.4 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.5 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 0.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.5 | 1.4 | GO:0036049 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.5 | 2.8 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
| 0.5 | 2.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.5 | 1.4 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.5 | 0.5 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.5 | 2.3 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.5 | 0.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.5 | 1.8 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.5 | 4.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.4 | 2.7 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 1.8 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.4 | 4.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.4 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.4 | 1.3 | GO:0015734 | taurine transport(GO:0015734) |
| 0.4 | 2.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 2.2 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
| 0.4 | 2.2 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.4 | 3.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.4 | 2.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 | 37.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.4 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.4 | 2.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.4 | 1.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.4 | 1.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 1.7 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.4 | 6.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.4 | 1.7 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.4 | 0.4 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.4 | 1.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.4 | 1.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.4 | 0.9 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 2.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.4 | 1.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.4 | 16.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.4 | 1.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.4 | 1.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 2.5 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.4 | 2.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.4 | 1.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.4 | 0.4 | GO:2000662 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.4 | 2.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 6.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 3.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.4 | 0.8 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.4 | 1.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.4 | 3.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.4 | 9.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.4 | 1.6 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.4 | 1.2 | GO:0048561 | establishment of organ orientation(GO:0048561) |
| 0.4 | 2.4 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 0.4 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 | 1.2 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 2.4 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.4 | 4.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.4 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.4 | 2.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.4 | 0.8 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.4 | 2.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.4 | 4.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.4 | 1.6 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 0.4 | 2.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 2.0 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.4 | 1.6 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.4 | 1.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 | 3.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.4 | 0.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.4 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.4 | 2.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.4 | 5.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.4 | 0.4 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 0.4 | 1.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 | 0.8 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 | 2.3 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 5.7 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.4 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 0.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 1.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.4 | 3.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 6.1 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.4 | 8.7 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.4 | 1.1 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.4 | 3.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.4 | 1.1 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.4 | 7.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.4 | 2.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 | 0.7 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.4 | 3.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.4 | 0.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.4 | 3.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.4 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.4 | 1.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.4 | 1.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 1.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.4 | 0.7 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.4 | 1.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.4 | 2.9 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.4 | 2.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 7.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.4 | 1.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.4 | 0.7 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.4 | 1.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.4 | 2.1 | GO:0046618 | drug export(GO:0046618) |
| 0.4 | 2.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 | 1.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 | 1.8 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.4 | 6.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.4 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.4 | 10.9 | GO:0051923 | sulfation(GO:0051923) |
| 0.3 | 2.4 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.3 | 1.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.3 | 0.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.3 | 0.3 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 0.3 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.3 | 1.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.3 | 1.0 | GO:0061017 | hepatic duct development(GO:0061011) hepatoblast differentiation(GO:0061017) |
| 0.3 | 9.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 | 0.7 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.3 | 0.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 0.7 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.3 | 3.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.3 | 1.0 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.3 | 0.7 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.3 | 2.0 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.3 | 1.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.3 | 6.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.3 | 1.0 | GO:0036255 | response to methylamine(GO:0036255) response to lipoic acid(GO:1903442) |
| 0.3 | 5.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.3 | 5.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.3 | 1.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.3 | 1.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.3 | 1.3 | GO:0009624 | response to nematode(GO:0009624) |
| 0.3 | 10.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.3 | 2.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.3 | 9.3 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.3 | 2.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 | 1.0 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 0.3 | 1.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 | 8.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 3.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.3 | 1.6 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.3 | 1.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.3 | 8.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.3 | 3.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 1.6 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.3 | 2.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 2.6 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.3 | 0.3 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.3 | 10.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 1.0 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.3 | 2.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 0.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 | 5.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 5.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.3 | 5.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.3 | 4.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 0.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.3 | 5.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 0.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 0.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.3 | 4.4 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 1.2 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.3 | 3.4 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.3 | 3.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.3 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.3 | 3.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.3 | 4.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.3 | 1.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 19.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 | 0.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.3 | 0.9 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
| 0.3 | 3.6 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.3 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 | 15.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.3 | 8.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.3 | 1.5 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.3 | 2.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
| 0.3 | 2.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.3 | 5.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 | 1.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.3 | 0.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.3 | 18.0 | GO:0061620 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.3 | 1.2 | GO:0060696 | regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) regulation of phospholipid catabolic process(GO:0060696) |
| 0.3 | 7.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 0.9 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.3 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.3 | 1.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 0.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.3 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 1.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 2.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.3 | 25.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.3 | 2.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.3 | 0.6 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.3 | 1.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.3 | 0.6 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
| 0.3 | 3.8 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.3 | 0.3 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.3 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.3 | 1.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.3 | 21.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 | 4.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.3 | 0.3 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
| 0.3 | 1.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 | 1.4 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.3 | 0.9 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.3 | 2.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.4 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 0.6 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.3 | 3.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 1.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.3 | 0.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.3 | 0.8 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.3 | 1.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.3 | 0.8 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 1.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.3 | 1.7 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 | 0.8 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.3 | 1.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.3 | 2.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.3 | 1.6 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.3 | 1.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 0.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.3 | 1.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.3 | 0.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.3 | 2.7 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.3 | 1.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.3 | 2.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.3 | 0.8 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.3 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.3 | 0.8 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.3 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.3 | 0.5 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 3.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 1.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.3 | 2.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.3 | 30.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.3 | 1.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 | 2.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 | 0.8 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.3 | 2.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.3 | 1.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 0.5 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.3 | 0.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 | 3.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.3 | 2.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 2.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.3 | 3.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.3 | 2.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.3 | 2.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 | 1.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 0.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 | 1.7 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.2 | 2.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 2.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.2 | 1.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.2 | 7.2 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 0.7 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.2 | 1.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 4.4 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.2 | 1.0 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.2 | 0.5 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.2 | 6.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 0.7 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.2 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.2 | 0.7 | GO:0060430 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) lung saccule development(GO:0060430) |
| 0.2 | 2.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 | 5.5 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.2 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 | 6.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 8.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.2 | 0.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 0.2 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 4.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.2 | 35.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 1.2 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 0.2 | 0.7 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.2 | 0.7 | GO:1903947 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.2 | 1.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.2 | 0.5 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 | 3.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 3.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.2 | 0.9 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 | 1.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 0.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
| 0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 1.8 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 | 0.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.2 | 0.2 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.2 | 0.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 3.9 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 2.5 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 0.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.2 | 3.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.2 | 4.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 0.7 | GO:0046645 | positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.2 | 1.8 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 2.2 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.2 | 2.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 1.3 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.2 | 6.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
| 0.2 | 4.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.2 | 0.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.2 | 2.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 | 0.9 | GO:1900111 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.2 | 0.9 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 0.7 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.2 | 0.2 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.2 | 0.7 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.2 | 1.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 0.7 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 2.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 1.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 4.5 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 3.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 0.9 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.2 | 1.5 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 2.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.2 | 4.0 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 15.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.2 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 52.8 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.2 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
| 0.2 | 1.7 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 2.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.2 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 2.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 2.5 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.2 | 0.4 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 0.2 | 2.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.2 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 2.7 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 1.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.2 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 | 1.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 | 0.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 1.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 0.2 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.2 | 0.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
| 0.2 | 3.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 | 1.6 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.2 | 2.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 18.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 6.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.2 | 7.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.2 | 0.8 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.2 | 6.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 | 0.2 | GO:0071650 | negative regulation of chemokine (C-C motif) ligand 5 production(GO:0071650) |
| 0.2 | 1.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
| 0.2 | 0.8 | GO:2000255 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 2.2 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.2 | 1.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 0.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 | 1.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 1.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.2 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 1.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.2 | 0.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 0.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.2 | 0.8 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 | 3.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 2.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 2.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.2 | 3.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.2 | 2.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.2 | 1.3 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 0.6 | GO:0090134 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.2 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 1.5 | GO:0036302 | atrioventricular canal development(GO:0036302) |
| 0.2 | 2.4 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.2 | 1.3 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 1.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 | 0.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 2.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 | 0.5 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.2 | 0.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 1.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 0.2 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
| 0.2 | 1.4 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.2 | 0.7 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.2 | 0.4 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.2 | 1.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 1.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 1.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.2 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.2 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 1.2 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 2.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 2.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 | 0.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.2 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 1.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 0.5 | GO:1901033 | initiation of primordial ovarian follicle growth(GO:0001544) positive regulation of response to reactive oxygen species(GO:1901033) |
| 0.2 | 0.5 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 | 2.0 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.2 | 0.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.2 | 3.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 0.5 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.2 | 0.5 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.2 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 0.8 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.2 | 1.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 2.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 0.5 | GO:0060482 | lobar bronchus development(GO:0060482) |
| 0.2 | 0.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 | 2.8 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.2 | 1.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.3 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 3.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 | 0.7 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 | 3.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 3.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 | 3.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 7.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.2 | 0.3 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 0.2 | 0.8 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.2 | 0.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.2 | 1.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.2 | 2.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 1.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.2 | 0.5 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.3 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.2 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 | 0.5 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.2 | 0.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.2 | 0.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 1.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.2 | 0.8 | GO:0046077 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.2 | 1.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 | 0.8 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 | 0.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.2 | 1.1 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.2 | 1.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 1.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.2 | 0.6 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 | 1.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.2 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.2 | 3.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.2 | 0.5 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.2 | 2.7 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.2 | 1.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 1.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.1 | 0.6 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 0.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 | 2.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 2.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.6 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 1.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 1.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 1.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 1.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.4 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.1 | 0.4 | GO:0042946 | glucoside transport(GO:0042946) |
| 0.1 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 11.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 1.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.1 | 0.7 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 2.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 3.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 3.3 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.4 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.5 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
| 0.1 | 3.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.1 | 3.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.1 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 0.1 | 0.4 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.1 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 | 0.8 | GO:0031343 | positive regulation of cell killing(GO:0031343) |
| 0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.8 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.1 | 0.8 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.1 | 0.4 | GO:0016122 | tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.1 | 0.4 | GO:0046713 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 2.5 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.1 | 1.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.3 | GO:0001768 | establishment of T cell polarity(GO:0001768) regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 | 0.4 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.1 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 2.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 3.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 0.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
| 0.1 | 0.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 3.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 1.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 3.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 0.4 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.1 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.1 | 2.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 5.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.4 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 0.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.1 | 1.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.1 | 0.4 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 | 1.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 | 0.7 | GO:0021557 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 2.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 0.8 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 1.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 | 4.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 2.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 2.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 | 0.3 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 4.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.1 | 0.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 1.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.8 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
| 0.1 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 3.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 0.8 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 1.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.6 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.1 | 0.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 2.4 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 4.3 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 4.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.1 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 0.4 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 1.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.2 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.1 | 1.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 0.4 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 0.1 | 3.8 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 1.5 | GO:0032196 | transposition(GO:0032196) |
| 0.1 | 0.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 1.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
| 0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 2.3 | GO:0006415 | translational termination(GO:0006415) |
| 0.1 | 0.6 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.1 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 0.4 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.1 | 0.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
| 0.1 | 1.2 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 0.5 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.5 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.1 | 1.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 3.2 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.1 | 0.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 1.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 1.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 32.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 2.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.2 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.1 | 2.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 47.8 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 1.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 1.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.8 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
| 0.1 | 0.4 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.3 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.1 | 0.3 | GO:0010043 | response to zinc ion(GO:0010043) |
| 0.1 | 0.4 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 1.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 0.6 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 0.3 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 | 0.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 1.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 1.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 4.1 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 0.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.1 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.1 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.5 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 0.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 1.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 0.1 | 10.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 5.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.3 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.1 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 0.1 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 1.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.2 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
| 0.1 | 0.8 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 2.1 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 1.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
| 0.1 | 1.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.6 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.1 | 0.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.1 | 0.2 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
| 0.1 | 0.6 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.1 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.1 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 1.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 1.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 1.5 | GO:0060039 | pericardium development(GO:0060039) |
| 0.1 | 0.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 4.8 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) regulation of early endosome to recycling endosome transport(GO:1902954) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 1.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 0.2 | GO:0009074 | aromatic amino acid family metabolic process(GO:0009072) aromatic amino acid family catabolic process(GO:0009074) |
| 0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.4 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.1 | 1.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 1.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.1 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 3.6 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.1 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.2 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.1 | 0.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 11.0 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.1 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
| 0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.1 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.2 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 0.3 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.1 | 0.3 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.1 | 1.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.2 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 | 0.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.1 | 0.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 0.4 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.0 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
| 0.0 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.0 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.6 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.5 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 4.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
| 0.0 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.0 | 0.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.1 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.0 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.0 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 | 2.6 | GO:0006901 | vesicle coating(GO:0006901) |
| 0.0 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) |
| 0.0 | 0.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 2.9 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.0 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.0 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 2.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.0 | 0.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 1.0 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 1.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.0 | 0.2 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.0 | 0.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.0 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.0 | 0.1 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.0 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
| 0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.2 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.0 | 1.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.0 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
| 0.0 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 1.5 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.0 | 0.3 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.0 | 0.4 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 | 0.2 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.0 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.0 | 0.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
| 0.0 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 1.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 | 0.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.1 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.0 | 0.1 | GO:0044878 | abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.0 | 0.3 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 0.1 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.0 | 0.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.2 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 0.0 | 0.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.0 | 0.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.0 | 0.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.0 | 0.0 | GO:0051230 | mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.0 | 0.3 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.0 | 0.0 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 | 0.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 24.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 3.0 | 18.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 2.6 | 5.3 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 2.1 | 10.3 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 1.9 | 5.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.8 | 5.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.6 | 6.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 1.6 | 7.9 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.6 | 4.7 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.5 | 32.0 | GO:0042627 | chylomicron(GO:0042627) |
| 1.5 | 18.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.5 | 13.4 | GO:0005579 | membrane attack complex(GO:0005579) |
| 1.4 | 4.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.4 | 16.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.3 | 7.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 1.2 | 6.2 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 1.1 | 18.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 1.1 | 11.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.1 | 16.6 | GO:0005861 | troponin complex(GO:0005861) |
| 1.1 | 10.6 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.0 | 4.1 | GO:0036029 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 1.0 | 13.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.0 | 3.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
| 1.0 | 9.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.0 | 3.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.9 | 49.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.9 | 4.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.8 | 18.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.8 | 3.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.7 | 3.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.7 | 5.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.6 | 1.9 | GO:0002140 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
| 0.6 | 2.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.6 | 7.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.6 | 11.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 1.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.6 | 5.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.6 | 5.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.6 | 4.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.6 | 3.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.6 | 1.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.6 | 4.5 | GO:0031415 | NatA complex(GO:0031415) |
| 0.5 | 6.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.5 | 39.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.5 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.5 | 1.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.5 | 12.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.5 | 2.6 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.5 | 5.2 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
| 0.5 | 6.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.5 | 6.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 2.0 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.5 | 2.8 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.5 | 1.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.5 | 4.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.5 | 87.3 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 8.2 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.5 | 52.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.4 | 0.9 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 1.3 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.4 | 1.3 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 5.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.4 | 1.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.4 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
| 0.4 | 2.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.4 | 1.2 | GO:0031430 | M band(GO:0031430) |
| 0.4 | 5.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 4.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.4 | 3.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 2.0 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
| 0.4 | 3.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 1.2 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.4 | 4.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.4 | 1.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 9.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.4 | 2.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.4 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.4 | 9.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 1.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.4 | 2.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.4 | 1.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.4 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.3 | 31.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.3 | 2.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.3 | 2.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.3 | 1.4 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.3 | 2.8 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.3 | 3.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 8.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.3 | 6.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 38.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 1.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.3 | 5.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 11.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.3 | 21.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 14.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 2.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.3 | 1.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 1.3 | GO:1990879 | CST complex(GO:1990879) |
| 0.3 | 4.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.3 | 2.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.3 | 3.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 4.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 2.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 19.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.3 | 1.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.3 | 0.9 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.3 | 10.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.3 | 2.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 7.5 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 1.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 2.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 2.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.3 | 21.5 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 0.8 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.3 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 3.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 25.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.3 | 4.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.3 | 2.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.3 | 1.1 | GO:0097196 | Shu complex(GO:0097196) |
| 0.3 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.3 | 0.8 | GO:0060342 | photoreceptor inner segment membrane(GO:0060342) |
| 0.3 | 2.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.3 | 1.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 1.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.3 | 1.6 | GO:0044753 | amphisome(GO:0044753) |
| 0.3 | 14.6 | GO:0000791 | euchromatin(GO:0000791) |
| 0.3 | 1.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 1.0 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.3 | 1.3 | GO:0008623 | CHRAC(GO:0008623) |
| 0.3 | 20.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 4.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.2 | 20.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 1.0 | GO:0005715 | late recombination nodule(GO:0005715) |
| 0.2 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 27.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 1.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 1.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 18.7 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 1.9 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.2 | 0.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.2 | 5.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.2 | 10.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 6.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.2 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.2 | 3.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 2.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 2.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 1.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 1.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 1.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.2 | 4.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 13.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 0.8 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 0.2 | 1.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 3.6 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
| 0.2 | 0.8 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.2 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 0.8 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.2 | 2.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 3.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 16.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 80.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.2 | 0.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.2 | 1.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 4.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 0.4 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.2 | 5.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 0.9 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 22.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 0.5 | GO:0030689 | Noc complex(GO:0030689) |
| 0.2 | 1.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 1.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.2 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 1.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 5.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 2.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 0.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.1 | 0.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.1 | 1.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.1 | 3.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 0.4 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.1 | 0.7 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.1 | 5.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 21.6 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 3.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.4 | GO:0097545 | axonemal outer doublet(GO:0097545) |
| 0.1 | 0.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) other organism cytoplasm(GO:0097679) |
| 0.1 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 2.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 6.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 0.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 3.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 19.8 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 7.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 2.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 2.2 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 2.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.1 | 20.6 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 9.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 6.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.1 | 34.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 1.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 0.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.1 | 3.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 3.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 1.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 3.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 3.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 1.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 5.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 127.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.1 | 1.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 0.4 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 7.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.1 | 10.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 2.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.1 | 6.3 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 1.2 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.1 | 0.4 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 0.3 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.1 | 0.3 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.7 | GO:0038201 | TOR complex(GO:0038201) |
| 0.1 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 0.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 5.8 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.3 | GO:0019867 | outer membrane(GO:0019867) |
| 0.1 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.7 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 3.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.1 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.1 | 1.9 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 2.0 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.0 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 4.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
| 0.0 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.0 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 0.2 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.0 | 1.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 1.1 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 5.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 2.6 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.0 | 9.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0030892 | mitotic cohesin complex(GO:0030892) |
| 0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.0 | 1.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 4.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 1.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 3.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 7.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.0 | 0.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.0 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.0 | 2.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 0.0 | GO:0001534 | radial spoke(GO:0001534) |
| 0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.0 | 2.8 | GO:0031674 | I band(GO:0031674) |
| 0.0 | 3.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.1 | GO:0090544 | BAF-type complex(GO:0090544) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 22.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 3.8 | 15.2 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 3.6 | 21.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 3.3 | 19.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 2.9 | 14.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 2.8 | 8.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 2.7 | 18.8 | GO:0019862 | IgA binding(GO:0019862) |
| 2.6 | 21.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 2.5 | 7.4 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 2.1 | 29.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 2.0 | 6.1 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 1.9 | 5.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.9 | 5.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.8 | 12.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 1.8 | 5.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 1.6 | 6.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 1.6 | 1.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.6 | 6.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 1.6 | 4.7 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 1.6 | 12.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 1.6 | 9.3 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 1.5 | 13.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.5 | 4.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.5 | 4.5 | GO:0017129 | triglyceride binding(GO:0017129) |
| 1.5 | 4.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.5 | 7.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.5 | 10.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 1.5 | 5.9 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 1.5 | 11.7 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 1.4 | 4.3 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 1.4 | 5.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 1.4 | 12.8 | GO:0005497 | androgen binding(GO:0005497) |
| 1.4 | 4.2 | GO:0052852 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 1.4 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 1.4 | 8.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 1.4 | 16.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.3 | 4.0 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.3 | 11.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.3 | 7.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 1.3 | 2.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 1.2 | 7.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 1.2 | 18.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 1.2 | 1.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.2 | 4.8 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.2 | 3.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 1.1 | 3.4 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 1.1 | 5.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 1.1 | 4.4 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 1.1 | 2.2 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.1 | 3.2 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 1.1 | 5.4 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.1 | 4.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 1.1 | 11.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.0 | 5.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.0 | 4.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 1.0 | 3.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 1.0 | 6.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.0 | 4.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 1.0 | 6.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 1.0 | 4.0 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
| 1.0 | 15.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.0 | 3.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.0 | 7.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.9 | 4.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.9 | 16.9 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.9 | 3.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.9 | 2.8 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.9 | 5.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.9 | 16.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.9 | 3.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.9 | 4.6 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.9 | 6.3 | GO:0042806 | fucose binding(GO:0042806) |
| 0.9 | 1.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.9 | 3.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.9 | 61.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.9 | 3.6 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.9 | 3.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.9 | 2.6 | GO:0033791 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity(GO:0033791) |
| 0.9 | 3.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.9 | 3.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.9 | 2.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.9 | 2.6 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
| 0.9 | 4.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.9 | 2.6 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.8 | 2.5 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.8 | 6.8 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.8 | 3.4 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.8 | 8.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.8 | 2.5 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.8 | 4.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.8 | 2.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.8 | 2.5 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.8 | 4.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.8 | 2.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.8 | 2.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.8 | 3.2 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.8 | 4.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.8 | 2.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.7 | 3.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.7 | 11.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.7 | 1.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.7 | 3.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.7 | 14.7 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.7 | 2.9 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.7 | 2.1 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.7 | 3.6 | GO:0004803 | transposase activity(GO:0004803) |
| 0.7 | 15.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.7 | 7.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.7 | 4.9 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.7 | 2.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.7 | 2.7 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.7 | 4.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.7 | 2.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.7 | 16.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.7 | 31.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.7 | 2.6 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.7 | 9.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.7 | 2.0 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.6 | 5.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.6 | 1.9 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 0.6 | 1.9 | GO:0015055 | secretin receptor activity(GO:0015055) |
| 0.6 | 3.8 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.6 | 3.8 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.6 | 6.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.6 | 5.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.6 | 8.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.6 | 4.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.6 | 5.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.6 | 11.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.6 | 3.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.6 | 8.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.6 | 2.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.6 | 1.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.6 | 4.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.6 | 5.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.6 | 2.4 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 5.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.6 | 3.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.6 | 2.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.6 | 1.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.6 | 92.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.6 | 13.6 | GO:0071949 | FAD binding(GO:0071949) |
| 0.6 | 1.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.6 | 3.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.6 | 1.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.6 | 7.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.6 | 2.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.6 | 8.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.5 | 9.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 3.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.5 | 1.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.5 | 4.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.5 | 2.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.5 | 2.7 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.5 | 2.7 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.5 | 1.6 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.5 | 5.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.5 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.5 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.5 | 12.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.5 | 2.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.5 | 106.0 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 2.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.5 | 1.6 | GO:0004411 | homogentisate 1,2-dioxygenase activity(GO:0004411) |
| 0.5 | 1.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.5 | 5.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.5 | 5.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.5 | 2.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.5 | 2.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.5 | 2.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.5 | 7.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.5 | 5.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.5 | 1.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 5.8 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.5 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.5 | 4.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 3.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.5 | 4.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.5 | 1.9 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.5 | 0.9 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.5 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.5 | 2.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 1.9 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 0.5 | 1.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.5 | 1.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.5 | 1.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.5 | 1.4 | GO:0036054 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 0.5 | 3.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.5 | 3.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.5 | 2.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.5 | 3.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.5 | 1.4 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.5 | 2.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.5 | 1.4 | GO:0004040 | amidase activity(GO:0004040) |
| 0.4 | 0.9 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.4 | 1.3 | GO:0005369 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 0.4 | 1.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.4 | 4.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.4 | 1.3 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.4 | 2.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 10.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.4 | 1.7 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 0.9 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.4 | 3.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.4 | 3.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 3.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.4 | 2.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.4 | 2.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.4 | 1.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.4 | 1.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.4 | 1.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.4 | 3.6 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 3.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.4 | 7.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 1.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.4 | 2.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.4 | 1.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.4 | 12.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.4 | 5.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.4 | 0.8 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.4 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 6.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.4 | 12.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.4 | 2.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.4 | 1.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.4 | 16.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.4 | 1.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.4 | 2.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 2.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.4 | 2.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.4 | 1.5 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.4 | 6.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.4 | 4.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.4 | 1.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.4 | 2.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.4 | 1.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.4 | 1.4 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.4 | 6.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.4 | 2.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.3 | 4.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.3 | 0.7 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.3 | 2.8 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.3 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 2.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.3 | 3.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.3 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 1.0 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.3 | 4.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.3 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.3 | 2.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.3 | 1.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.3 | 1.4 | GO:0070404 | NADH binding(GO:0070404) |
| 0.3 | 1.4 | GO:0004733 | pyridoxamine-phosphate oxidase activity(GO:0004733) |
| 0.3 | 1.0 | GO:0004375 | glycine dehydrogenase (decarboxylating) activity(GO:0004375) oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor(GO:0016642) vitamin B6 binding(GO:0070279) pyridoxal binding(GO:0070280) |
| 0.3 | 3.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.3 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.3 | 1.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.3 | 2.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 3.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 1.6 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.3 | 9.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 1.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.3 | 2.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.3 | 3.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 1.6 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.3 | 2.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 3.9 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 6.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.3 | 4.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.3 | 28.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.3 | 1.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.3 | 1.0 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.3 | 20.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.3 | 1.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.3 | 2.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.3 | 1.9 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.3 | 4.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 1.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.3 | 1.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.3 | 0.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.3 | 2.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.3 | 1.3 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.3 | 2.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 1.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 2.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.3 | 2.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 2.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.3 | 2.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 1.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.3 | 0.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 0.9 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 8.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.3 | 2.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.3 | 6.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 4.9 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.3 | 2.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.3 | 0.9 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.3 | 4.0 | GO:0019864 | IgG binding(GO:0019864) |
| 0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.3 | 8.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.3 | 0.8 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.3 | 2.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.3 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.3 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.3 | 0.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.3 | 1.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 8.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.3 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 0.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.3 | 6.6 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.3 | 8.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 3.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.3 | 2.7 | GO:0060229 | lipase activator activity(GO:0060229) |
| 0.3 | 1.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.3 | 1.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.3 | 1.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.3 | 0.8 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.3 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.3 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 5.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 1.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.3 | 0.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 5.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 1.3 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.3 | 1.3 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.3 | 8.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.3 | 0.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.3 | 1.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.3 | 2.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.3 | 3.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 0.8 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.3 | 1.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.3 | 38.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.3 | 2.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 1.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.3 | 1.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.3 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 0.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.3 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.3 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 2.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 1.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.2 | 2.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 0.7 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.2 | 1.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.2 | 0.7 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.2 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 1.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 0.7 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.2 | 2.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 2.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.2 | 1.0 | GO:0030395 | lactose binding(GO:0030395) |
| 0.2 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 0.7 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 1.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.2 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 3.1 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 1.7 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 3.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.2 | 1.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 1.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 6.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 0.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.2 | 22.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.2 | 9.2 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 2.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 0.2 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.2 | 1.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.2 | 4.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 3.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.2 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.2 | 0.9 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 2.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 1.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 2.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.2 | 0.7 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.2 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 0.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.2 | 0.6 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.2 | 1.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.2 | 2.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.2 | 12.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 0.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 1.7 | GO:0016208 | AMP binding(GO:0016208) |
| 0.2 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 1.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.2 | 1.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.2 | 2.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.2 | 6.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.2 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 1.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 3.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.6 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.2 | 1.0 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 1.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.2 | 2.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 7.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.2 | 1.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.2 | 3.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.2 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.2 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 2.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 2.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 0.6 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 2.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 8.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.2 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 1.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.2 | 2.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 5.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.2 | 0.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.2 | 2.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.2 | 2.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.2 | 1.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.2 | 4.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 1.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.2 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 4.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 0.7 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.2 | 2.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.2 | 5.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.2 | 3.5 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.2 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.2 | 1.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.2 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 2.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.2 | 9.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 4.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.2 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 3.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 1.2 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.2 | 7.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.2 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 0.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.2 | 9.3 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 1.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 7.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 14.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 2.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 0.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.2 | 6.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 2.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.2 | 4.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 0.7 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.2 | 2.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 7.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 1.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.2 | 0.8 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.2 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 0.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.2 | 0.8 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.2 | 0.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 0.6 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.2 | 1.5 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.2 | 4.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 3.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.2 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 0.9 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 0.3 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 0.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 36.9 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.1 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 2.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.1 | 6.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.4 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 3.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 4.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 4.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 3.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 3.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 2.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.1 | 0.7 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.1 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.8 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 2.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 33.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 4.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.1 | 0.4 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
| 0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 2.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 1.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.1 | 3.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 1.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 1.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 2.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 0.4 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.1 | 0.6 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
| 0.1 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 1.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.1 | 3.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.5 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 8.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 2.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 6.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 2.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 12.2 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.1 | 0.4 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.1 | 0.5 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 1.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 2.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.1 | 0.4 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.1 | 0.3 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.1 | 0.3 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 1.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 7.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 1.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 3.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 0.4 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 1.0 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.1 | 3.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.1 | 4.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.1 | 1.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 2.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.3 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.1 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.1 | 0.3 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
| 0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.1 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.3 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 32.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.1 | 0.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 2.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 0.7 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.1 | 0.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 23.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 3.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 11.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 3.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 1.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.1 | 11.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.1 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 3.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.5 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.5 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 6.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 10.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 1.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.3 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 1.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.1 | 6.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 5.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.1 | 0.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 1.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 5.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 5.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 2.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 1.0 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 1.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 1.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 2.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.2 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 1.1 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.1 | 3.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 8.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 1.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.1 | 0.2 | GO:0016436 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
| 0.1 | 1.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
| 0.1 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.2 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.0 | 2.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 2.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.0 | 0.2 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.0 | 1.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.0 | 2.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 10.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.7 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 1.0 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.0 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.0 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.0 | 25.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.6 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.0 | 0.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.0 | 0.2 | GO:0004078 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.0 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.0 | 2.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 1.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 2.0 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 1.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 0.2 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.0 | 1.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 17.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 1.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.1 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 2.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.0 | 4.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.0 | 0.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.0 | 0.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 3.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.0 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.0 | 0.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.0 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 1.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.1 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 1.8 | 1.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.8 | 53.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 66.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.7 | 18.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.6 | 3.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.6 | 5.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.5 | 52.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 45.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.4 | 4.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 6.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.4 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.4 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.4 | 5.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.4 | 25.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.3 | 9.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 10.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.3 | 28.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 10.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.3 | 7.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.3 | 6.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 3.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.3 | 24.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.3 | 4.5 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 7.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.3 | 10.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 2.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.3 | 5.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 1.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 7.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 4.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 8.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 13.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 84.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 7.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 3.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 9.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 4.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 5.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 6.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.2 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 7.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 3.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 17.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 4.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 2.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 4.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 6.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 5.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 8.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 1.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 3.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 4.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 2.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 2.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 3.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 5.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 2.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 2.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 8.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 5.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 4.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 3.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 5.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 2.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 5.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 2.3 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.0 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 50.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 2.0 | 35.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 1.9 | 48.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.2 | 21.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 1.1 | 29.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 1.1 | 20.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 1.0 | 18.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 1.0 | 30.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.9 | 12.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.9 | 19.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.8 | 20.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.8 | 8.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.7 | 9.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.7 | 18.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.6 | 19.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.6 | 8.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.6 | 48.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.6 | 45.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.6 | 6.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.6 | 6.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 59.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.5 | 6.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.5 | 27.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.5 | 44.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.5 | 6.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.5 | 6.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.5 | 11.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.5 | 5.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 14.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.4 | 12.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 2.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.4 | 12.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 2.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.4 | 6.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.4 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.4 | 28.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 3.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 7.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.3 | 10.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.3 | 34.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.3 | 2.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 6.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.3 | 11.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 31.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.3 | 16.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.3 | 6.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.3 | 4.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.3 | 11.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.3 | 20.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.3 | 21.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.3 | 3.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 7.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 6.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.3 | 12.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.3 | 4.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 3.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.2 | 62.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 6.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 6.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 7.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 4.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 3.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 10.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 5.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.2 | 12.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 5.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 0.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.2 | 2.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 2.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 3.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 11.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 3.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.2 | 8.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 9.1 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 4.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 4.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 9.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 23.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 8.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 6.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 3.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 3.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.2 | 2.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 6.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 18.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 5.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 4.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 0.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.2 | 3.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.1 | 3.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 2.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 3.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 4.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.1 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 2.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 6.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 2.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 2.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 3.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 0.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 2.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 3.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 13.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.1 | 3.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.1 | 2.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.1 | 2.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
| 0.1 | 3.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 4.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 4.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 3.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 1.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 1.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 4.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 2.3 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.1 | 1.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.1 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 1.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 3.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 19.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 16.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.1 | 1.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 4.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 2.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 1.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 2.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 5.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 2.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.0 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 1.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 0.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 0.6 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 0.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 1.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |